GraniteShares Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.37M Sell
2,582
-284
-10% -$288K 1.71% 18
2025
Q4
$3.08M Sell
2,866
-508
-15% -$486K 1.87% 4
2025
Q3
$2.57M Buy
3,374
+148
+5% +$110K 1.49% 36
2025
Q2
$2.51M Buy
3,226
+95
+3% +$73.8K 1.55% 37
2025
Q1
$2.59M Sell
3,131
-331
-10% -$275K 1.65% 30
2024
Q4
$2.67M Buy
+3,462
New +$2.87M 1.69% 5
2023
Q3
Sell
-2,667
Closed -$1.25M 121
2023
Q2
$1.25M Sell
2,667
-284
-10% -$119K 1.13% 43
2023
Q1
$1.01M Buy
2,951
+76
+3% +$25.6K 0.9% 53
2022
Q4
$1.05M Sell
2,875
-468
-14% -$166K 0.87% 29
2022
Q3
$1.08M Sell
3,343
-609
-15% -$193K 0.88% 28
2022
Q2
$1.28M Sell
3,952
-243
-6% -$72.9K 0.94% 27
2022
Q1
$1.2M Sell
4,195
-405
-9% -$104K 0.65% 31
2021
Q4
$1.27M Buy
+4,600
New +$1.17M 0.59% 33

Other funds holding LLY

GraniteShares Advisors's LLY Position: Q1 2026 in Review

GraniteShares Advisors reduced its Eli Lilly (LLY) stake by 9.9% in Q1 2026, selling an estimated $288K and leaving 2,582 shares worth $2.37M. The position accounts for 1.71% of the portfolio, ranked #18.

GraniteShares Advisors first reported a position in LLY in Q4 2021 and has held it in 13 quarters since. The position peaked at $3.08M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • GraniteShares Advisors held 2,582 shares of Eli Lilly worth $2.37M as of Q1 2026.
  • GraniteShares Advisors sold 284 Eli Lilly shares in Q1 2026, an estimated $288K.
  • Eli Lilly made up 1.71% of GraniteShares Advisors's portfolio in Q1 2026, its #18 holding.
  • GraniteShares Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 13 quarters since.
  • GraniteShares Advisors's Eli Lilly position peaked at $3.08M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on GraniteShares Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.